Dearborn, Farmington Hills, Grosse Pointe, Royal Oak, Southeast Michigan, Taylor, Trenton, Troy, Wayne

Body Fluid Culture – Specimen Collection Update

Effective June 1, 2026, Corewell Health Microbiology Laboratory in Southeast Michigan is updating specimen collection criteria for body fluid specimens. Microbiology will no longer accept red top vacutainer tubes as a collection device for body fluids (i.e. synovial fluid, pleural fluid, peritoneal fluid, etc). Collection criteria information has been updated in Corewell’s Lab Test Directory to reflect this change. Test order for body fluid cultures is LAB2111016 (aerobic culture) and commonly accompanied by LAB233 (anaerobic culture). Continue Reading

Niles, Southwest Michigan, St. Joseph, Watervliet

Changes to Outpatient Occult Blood (FIT) Stool Testing (Corewell Health Southwest Region)

Effective Tuesday, May 26, 2026, outpatient occult blood testing (stool) will no longer be performed at Corewell Health Lakeland St. Joseph Laboratory and will instead be routed or mailed to Corewell Health Reference Laboratory in Grand Rapids, MI (35 Michigan St.) for processing.

In addition, the collection kits will be updated from OC-Light™ S FIT collection kits to OC-Auto™ collection kits. Continue Reading

Corewell Health System, Hematology

Schistocyte Review Test Now Available to Order

Effective Wednesday, April 29, 2026, Schistocyte Review (LAB1231565) will be available to order across all Corewell Health Laboratories Hematology Departments.

This new orderable supports alignment across Corewell Health regions by standardizing schistocyte assessment practices, ensuring high‑quality testing, and delivering a consistent patient care experience system‑wide.

Continue Reading

Blood Bank, Compliance & Safety, Corewell Health System

Reminder Pre‑Surgical Type & Screen Orders

When ordering a Pre‑surgical Type & Screen, all required order questions must be completed accurately. These answers drive specimen routing, collection timing, and blood bank workflow in Epic.

Epic uses your responses to ensure testing is performed by the correct blood bank at the correct time. Incomplete or incorrect information can result in misrouted specimens, delays, rework, or redraws.

Continue Reading

General Information

Updated: Acute Myeloid Leukemia (AML) Probe Panel by FISH

Effective 4/15/2026, in accordance with the 2024 American College of Medical Genetics and Genomic Technical Laboratory Standards, the Acute Myeloid Leukemia (AML) Probe Panel by FISH will now include:

• -5/5q Deletion
• -7/7q Deletion
• RUNX1::RUNX1T1 t(8;21) Fusion
• NUP98 (11p15.4) Rearrangement
• KMT2A (MLL) (11q23) Rearrangement
• CBFB::MYH11 inv(16) and t(16;16) Fusion
• TP53 (17p13.1) Deletion

The panel will no longer include BCR::ABL t(9;22) and PML::RARA t(15;17). These tests may still be ordered independently.

Additional Resource Link: ACMG Technical Standard Section E6.1-6.6 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in neoplastic blood, bone marrow, and lymph nodes (https://www.gimjournal.org/article/S1098-3600(23)01070-5/fulltext)

Epic Code: LAB2111348

General Information, Test Utilization

New PSA Screening Order Validation Rules

What’s Changing?

Beginning March 9, 2026, a new Order Validation Rules in Epic will apply to all PSA Screening orders. These rules act as hard stops and must be corrected before the order can be signed.

Applies to:

• Prostate Specific Antigen (PSA), Screening [LAB116]

Epic will stop the order if:

Diagnosis Code Is Not Z12.5. Z12.5 (Screening for Prostate Cancer) is required for all PSA Screening orders.

Patient Is <40 Years Old With BCBS Coverage. BCBS does not cover PSA Screening for this group.

Patient Is <50 Years Old With Medicare / Medicare Advantage. Medicare does not deem PSA Screening medically necessary before age 50.

Screening Was Performed Within the Past 11 Months. Annual screening limits apply; users must change the expected date if needed.


Important for Providers Ordering Outside Epic

External practices will not see Epic’s validation warnings, but the draw site (phlebotomy team) will.

What Happens at the Draw Site?

If a paper/EMR PSA Screening order violates any rule:

1. Phlebotomy attempts to enter the order.
2. A hard stop fires in Epic.
3. The phlebotomist cannot override the alert.
4. The order cannot be placed, even with a signed requisition.
5. Staff will:

Inform the patient
Contact the ordering provider for correction
Hold the draw until the provider updates the order

This may require the patient to return if changes can’t be made immediately.

How Providers Can Prevent Delays

✔ Use Z12.5 for all PSA Screening orders
✔ Confirm age + insurance coverage requirements
✔ Ensure no PSA Screening has occurred in the past 11 months
✔ Order a diagnostic PSA instead of a screening when appropriate (symptoms, abnormal findings, ongoing monitoring)

 

 

Advanced Technology Laboratory

New Test Available: Myxoid Liposarcoma Panel by FISH

We are pleased to announce the launch of the Myxoid Liposarcoma Panel by Fluorescence in situ Hybridization (FISH), now available for clinical ordering on Formalin-fixed, paraffin-embedded (FFPE) tissue.

The Myxoid Liposarcoma Panel by FISH includes:

  • CHOP (DDIT3) (12q13) Rearrangement
  • FUS (16p11) Rearrangement

These probes may also be ordered individually.


Test Ordering Information


Questions? We’re Here to Help

For additional clinical details or follow-up questions regarding this test, please use the contact us link above.